The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement: Review: ISHEN consensus statement for hepatic encephalopathy trials
Open accessAbstract
BACKGROUND: The clinical classification of hepatic encephalopathy is largely subjective, which has led to difficulties in designing trials in this field. AIMS: To review the current classification of hepatic encephalopathy and to develop consensus guidelines on the design and conduct of future clinical trials. METHODS: A round table was convened at the 14th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) meeting. Key discussion points were the nomenclature of hepatic encephalopathy and the selection of patients, standards of care and end-points for assessing the treatment and secondary prevention of hepatic encephalopathy. RESULTS: It was generally agreed that severity assessment of hepatic encephalopathy in patients with cirrhosis, whether made clinically or more objectively, should be continuous rather than categorical, and a system for assessing the SONIC (Spectrum of Neuro-cognitive Impairment in Cirrhosis) was proposed. Within this system, patients currently classified as having minimal hepatic encephalopathy and Grade I hepatic encephalopathy would be classified as having Covert hepatic encephalopathy, whereas those with apparent clinical abnormalities would continue to be classified as overt hepatic encephalopathy. Some aspects of the terminology require further debate. Consensus was also reached on the patient populations, standards of care and endpoints to assess clinical trial outcomes. However, some compromises had to be made as there is considerable inter- and intravariability in the availability of some of the more objective surrogate performance markers. CONCLUSIONS: The objectives of the round table were met. Robust, defendable guidelines for the conduct of future studies into hepatic encephalopathy have been provided. Outstanding issues are few and will continue to be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., & Blei, A. T. (2002) · Hepatology · doi:10.1053/jhep.2002.31250 · Cited by 2,043
Self-citationSarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Self-citationNeuropsychological characterization of hepatic encephalopathy
Weissenborn, K., Ennen, J. C., Schomerus, H., Rückert, N., & Hecker, H. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00026-5 · Cited by 796
Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., de Silva, H. J., Hamid, S. S., Jalan, R., Komolmit, P., et al. (2009) · Hepatology International · doi:10.1007/s12072-008-9106-x · Cited by 763
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L. B., & Levy, L. L. (1977) · PubMed · Cited by 641
Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L., & Levy, L. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80135-2 · Cited by 628
Blei, A. T., & Córdoba, J. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03964.x · Cited by 527
THE ELECTROENCEPHALOGRAPH IN LIVER DISEASE
Parsons-Smith, B. G., Summerskill, W. H. J., Dawson, A. M., & Sherlock, S. (1957) · The Lancet · doi:10.1016/s0140-6736(57)90005-3 · Cited by 422
Hassanein, T. I., Tofteng, F., Brown, R. S., McGuire, B., Lynch, P., Mehta, R., Larsen, F. S., Gornbein, J., Stange, J., & Blei, A. T. (2007) · Hepatology · doi:10.1002/hep.21930 · Cited by 407
THE ACQUIRED (NON-WILSONIAN) TYPE OF CHRONIC HEPATOCEREBRAL DEGENERATION
VICTOR, M., ADAMS, R. D., & COLE, M. (1965) · Medicine · doi:10.1097/00005792-196509000-00001 · Cited by 405
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., & Häussinger, D. (2002) · Hepatology · doi:10.1053/jhep.2002.30957 · Cited by 397
Bajaj, J. S., Wade, J. B., & Sanyal, A. J. (2009) · Hepatology · doi:10.1002/hep.23216 · Cited by 342
Self-citationSharma, B. C., Sharma, P., Agrawal, A., & Sarin, S. K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.056 · Cited by 325
Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy
Bajaj, J. S., Schubert, C. M., Heuman, D. M., Wade, J. B., Gibson, D. P., Topaz, A., Saeian, K., Hafeezullah, M., Bell, D. E., Sterling, R. K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.015 · Cited by 302
Self-citationPrevalence and natural history of subclinical hepatic encephalopathy in cirrhosis
Das, A., Dhiman, R. K., Saraswat, V. A., Verma, M., & Naik, S. R. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02487.x · Cited by 298
Characteristics of Minimal Hepatic Encephalopathy
Amodio, P., Montagnese, S., Gatta, A., & Morgan, M. Y. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043975.01841.de · Cited by 292
Self-citationAllard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247
Burkhard, P. R., Delavelle, J., Du Pasquier, R., & Spahr, L. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.521 · Cited by 245
Bajaj, J. S., Heuman, D. M., Wade, J. B., Gibson, D. P., Saeian, K., Wegelin, J. A., Hafeezullah, M., Bell, D. E., Sterling, R. K., Stravitz, R. T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.08.061 · Cited by 244
Self-citationReview article: the modern management of hepatic encephalopathy
BAJAJ, J. S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04211.x · Cited by 243
Self-citationInhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy
Bajaj, J. S., Hafeezullah, M., Franco, J., Varma, R. R., Hoffmann, R. G., Knox, J. F., Hischke, D., Hammeke, T. A., Pinkerton, S. D., & Saeian, K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.021 · Cited by 225
Self-citationNew assessment of hepatic encephalopathy
Córdoba, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.015 · Cited by 216
Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy
Schomerus, H., & Hamster, W. (2001) · Metabolic Brain Disease · doi:10.1023/a:1011610427843 · Cited by 206
Riggio, O., Efrati, C., Catalano, C., Pediconi, F., Mecarelli, O., Accornero, N., Nicolao, F., Angeloni, S., Masini, A., Ridola, L., et al. (2005) · Hepatology · doi:10.1002/hep.20905 · Cited by 193
Bajaj, J. S., Saeian, K., Verber, M., Hischke, D., Hoffmann, R. G., Franco, J., Varma, R. R., & Rao, S. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01048.x · Cited by 163
Self-citationHepatic Encephalopathy and Fitness to Drive
Kircheis, G., Knoche, A., Hilger, N., Manhart, F., Schnitzler, A., Schulze, H., & Häussinger, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.003 · Cited by 160
Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients
Bajaj, J. S., Sanyal, A. J., Bell, D. E., Gilles, H., & Heuman, D. M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04257.x · Cited by 139
Self-citationMontagnese, S., Amodio, P., & Morgan, M. Y. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043977.11113.2a · Cited by 124
Self-citationEvidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy
Riggio, O., Ridola, L., Pasquale, C., Nardelli, S., Pentassuglio, I., Moscucci, F., & Merli, M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.002 · Cited by 108
Liver transplantation improves hepatic myelopathy: Evidence by three cases
Weißenborn, K., Tietge, U. J. F., Bokemeyer, M., Mohammadi, B., Bode, U., Manns, M. P., & Caselitz, M. (2003) · Gastroenterology · doi:10.1053/gast.2003.50062 · Cited by 97
Dispelling myths in the treatment of hepatic encephalopathy
Shawcross, D. L., & Jalan, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17832-5 · Cited by 97
Self-citationIntroduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)
Hassanein, T., Hilsabeck, R. C., & Perry, W. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9895-0 · Cited by 93
Improvement in chronic hepatocerebral degeneration following liver transplantation
Powell, E. E., Pender, M. P., Chalk, J. B., Parkin, P. J., Strong, R. W., Lynch, S. V., Kerlin, P., Cooksley, W. G. E., Cheng, W., & Powell, L. W. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90036-z · Cited by 92
Mullen, K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1746-6342.2006.03216.x · Cited by 82
Self-citationHassanein, T., Blei, A. T., Perry, W., Hilsabeck, R. C., Stange, J., Larsen, F. S., Brown, R. S., Caldwell, S. H., McGuire, B. M., Nevens, F., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.160 · Cited by 82
Review article: the current pharmacological therapies for hepatic encephalopathy
Bass, N. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1746-6342.2006.03218.x · Cited by 75
Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis
Montagnese, S., Jackson, C. D., & Morgan, M. Y. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.015 · Cited by 73
Self-citationRifai, K., Kribben, A., Gerken, G., Haag, S. F., Herget‐Rosenthal, S., Treichel, U., Betz, C., Sarrazin, C., Vlierberghe, H. V., Hoste, E. A. J., et al. (2010) · Journal of Hepatology · doi:10.1016/s0168-8278(10)60008-6 · Cited by 51
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Self-citationClinical states of cirrhosis and competing risks
D'Amico, G., Morabito, A., D'Amico, M., Pasta, L., Malizia, G., Rebora, P., & Valsecchi, M. G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.020 · Cited by 536
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.013 · Cited by 470
Self-citationWijdicks, E. F. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600561 · Cited by 444
Metadata
- Authors
- Bajaj, J. S., Cordoba, J., Mullen, K. D., Amodio, P., Shawcross, D. L., Butterworth, R. F., & Morgan, M. Y.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-02-09
- Volume
- 33
- Issue
- 7
- Pages
- 739-747
- ISSN
- 0269-2813 (ISSN-L)
- OpenAlex
- W1486067581
- Cited by
- 350
- References
- 40
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.